Diclofenac-induced acute corneal melt after collagen crosslinking for keratoconus

Cornea

Volumn 29, Issue 1, 2010, Pages 117-119

  Gokhale, Nikhil S ^a   Vemuganti, Geeta K ^b  

^a Gokhale Eye Hospital and Eyebank   (India)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

Collagen crosslinking; Corneal melt; Keratoconus

Indexed keywords

CARBOXYMETHYLCELLULOSE; COLLAGEN; DEXAMETHASONE; DICLOFENAC; DOXYCYCLINE; MILFLOX; MOXIFLOXACIN; OFLO DM; OFLOXACIN; PARACAIN; PROCAINE; PROXYMETACAINE; REFRESH TEARS; TISSUE ADHESIVE; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PHOTOSENSITIZING AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CONTACT LENS; CORNEA PERFORATION; HUMAN; INFLAMMATORY INFILTRATE; KERATOCONUS; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; CORNEA DISEASE; CORNEA STROMA; METABOLISM; PHOTOCHEMOTHERAPY; ULTRAVIOLET RADIATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLLAGEN; CORNEAL DISEASES; CORNEAL PERFORATION; CORNEAL STROMA; DICLOFENAC; HUMANS; KERATOCONUS; KERATOPLASTY, PENETRATING; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TISSUE ADHESIVES; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 75649152116     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181a06c31     Document Type: Article

References (9)

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135: 620-627.
2. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin crosslinking of the cornea. Cornea. 2007;26:385-389.
3. Mazzotta C, Balestrazzi A, Baiocchi S, et al. Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation. Clin Experiment Ophthalmol. 2007;35: 580-582.
4. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40.
5. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108:936-944.
6. Gabison EE, Chastang P, Menashi S, et al. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases. Ophthalmology. 2003;110:1626-1631.
7. O'Brien TP, Li QJ, Sauerburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology. 2001;108:656-659.
8. Rosenwasser GO, Holland S, Pflugfelder SC, et al. Topical anesthetic abuse. Ophthalmology. 1990;97:967-972.
9. Moreira LB, Kasetsuwan N, Sanchez D, et al. Toxicity of topical anesthetic agents to human keratocytes in vivo. J Cataract Refract Surg. 1999;25: 975-980.